{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:01:36Z","timestamp":1783105296178,"version":"3.54.6"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T00:00:00Z","timestamp":1323129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1038\/nrneph.2011.190","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T11:42:15Z","timestamp":1323171735000},"page":"122-128","source":"Crossref","is-referenced-by-count":80,"title":["The renaissance of corticotropin therapy in proteinuric nephropathies"],"prefix":"10.1038","volume":"8","author":[{"given":"Rujun","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"key":"BFnrneph2011190_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1749-6632.2009.04434.x","volume":"1163","author":"RM Dores","year":"2009","unstructured":"Dores, R. M. Adrenocorticotropic hormone, melanocyte-stimulating hormone, and the melanocortin receptors: revisiting the work of Robert Schwyzer: a thirty-year retrospective. Ann. NY Acad. Sci. 1163, 93\u2013100 (2009).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrneph2011190_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/adc.28.141.372","volume":"28","author":"GC Arneil","year":"1953","unstructured":"Arneil, G. C. & Wilson, H. E. A.C.T.H. in nephrosis. Arch. Dis. Child. 28, 372\u2013380 (1953).","journal-title":"Arch. Dis. Child."},{"key":"BFnrneph2011190_CR3","first-page":"152","volume":"85","author":"CF Piel","year":"1956","unstructured":"Piel, C. F. Management of nephrosis; the use of long continued hormone therapy. Calif. Med. 85, 152\u2013156 (1956).","journal-title":"Calif. Med."},{"key":"BFnrneph2011190_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1172\/JCI102936","volume":"33","author":"HD Lauson","year":"1954","unstructured":"Lauson, H. D., Forman, C. W., Mc, N. H., Mattar, G. & Barnett, H. L. The effect of corticotropin (ACTH) on glomerular permeability to albumin in children with the nephrotic syndrome. J. Clin. Invest. 33, 657\u2013664 (1954).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011190_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/ndt\/15.7.940","volume":"15","author":"AL Berg","year":"2000","unstructured":"Berg, A. L. & Arnadottir, M. ACTH revisited--potential implications for patients with renal disease. Nephrol. Dial. Transplant. 15, 940\u2013942 (2000).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2011190_CR6","first-page":"268","volume":"20","author":"C Ponticelli","year":"2007","unstructured":"Ponticelli, C. Membranous nephropathy. J. Nephrol. 20, 268\u2013287 (2007).","journal-title":"J. Nephrol."},{"key":"BFnrneph2011190_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1210\/er.2006-0034","volume":"27","author":"RD Cone","year":"2006","unstructured":"Cone, R. D. Studies on the physiological functions of the melanocortin system. Endocr. Rev. 27, 736\u2013749 (2006).","journal-title":"Endocr. Rev."},{"key":"BFnrneph2011190_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.2174\/1389450033490858","volume":"4","author":"J Voisey","year":"2003","unstructured":"Voisey, J., Carroll, L. & van Daal, A. Melanocortins and their receptors and antagonists. Curr. Drug Targets 4, 586\u2013597 (2003).","journal-title":"Curr. Drug Targets"},{"key":"BFnrneph2011190_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00060793-200106000-00002","volume":"8","author":"A Penhoat","year":"2001","unstructured":"Penhoat, A., Naville, D. & Begeot, M. The adrenocorticotropic hormone receptor. Curr. Opin. Endocrinol. Diabetes 8, 112\u2013117 (2001).","journal-title":"Curr. Opin. Endocrinol. Diabetes"},{"key":"BFnrneph2011190_CR10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1681\/ASN.2009101025","volume":"21","author":"A Lindskog","year":"2010","unstructured":"Lindskog, A. et al. Melanocortin 1 receptor agonists reduce proteinuria. J. Am. Soc. Nephrol. 21, 1290\u20131298 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011190_CR11","doi-asserted-by":"publisher","first-page":"548A","DOI":"10.1681\/ASN.2009050479","volume":"21","author":"R Gong","year":"2010","unstructured":"Gong, R. & Dworkin, L. D. ACTH (Acthar Gel) prevents proteinuria and renal injury in the remnant kidney: Evidence for direct podocyte protection. J. Am. Soc. Nephrol. 21, 548A (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011190_CR12","first-page":"73","volume":"38","author":"V Chhajlani","year":"1996","unstructured":"Chhajlani, V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem. Mol. Biol. Int. 38, 73\u201380 (1996).","journal-title":"Biochem. Mol. Biol. Int."},{"key":"BFnrneph2011190_CR13","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1242\/jeb.035121","volume":"212","author":"E Sanchez","year":"2009","unstructured":"Sanchez, E., Rubio, V. C. & Cerda-Reverter, J. M. Characterization of the sea bass melanocortin 5 receptor: a putative role in hepatic lipid metabolism. J. Exp. Biol. 212, 3901\u20133910 (2009).","journal-title":"J. Exp. Biol."},{"key":"BFnrneph2011190_CR14","doi-asserted-by":"publisher","first-page":"R560","DOI":"10.1152\/ajpregu.00279.2005","volume":"290","author":"XP Ni","year":"2006","unstructured":"Ni, X. P., Bhargava, A., Pearce, D. & Humphreys, M. H. Modulation by dietary sodium intake of melanocortin 3 receptor mRNA and protein abundance in the rat kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R560\u2013R567 (2006).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrneph2011190_CR15","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.transproceed.2008.07.101","volume":"40","author":"YS Lee","year":"2008","unstructured":"Lee, Y. S., Park, J. J. & Chung, K. Y. Change of melanocortin receptor expression in rat kidney ischemia-reperfusion injury. Transplant. Proc. 40, 2142\u20132144 (2008).","journal-title":"Transplant. Proc."},{"issue":"Suppl. 1","key":"BFnrneph2011190_CR16","first-page":"49","volume":"6","author":"P Schwandt","year":"1982","unstructured":"Schwandt, P. & Richter, W. O. Effects of pituitary peptides on fat mobilisation. Int. J. Obes. 6 (Suppl. 1), 49\u201354 (1982).","journal-title":"Int. J. Obes."},{"key":"BFnrneph2011190_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2796.1991.tb00332.x","volume":"229","author":"AL Berg","year":"1991","unstructured":"Berg, A. L., Hansson, P. & Nilsson-Ehle, P. ACTH 1\u201324 decreases hepatic lipase activities and low density lipoprotein concentrations in healthy men. J. Intern. Med. 229, 201\u2013203 (1991).","journal-title":"J. Intern. Med."},{"key":"BFnrneph2011190_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/ki.1996.346","volume":"50","author":"AL Berg","year":"1996","unstructured":"Berg, A. L. & Nilsson-Ehle, P. ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney disease. Kidney Int. 50, 538\u2013542 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph2011190_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/301255a0","volume":"301","author":"A Beloff-Chain","year":"1983","unstructured":"Beloff-Chain, A., Morton, J., Dunmore, S., Taylor, G. W. & Morris, H. R. Evidence that the insulin secretagogue, beta-cell-tropin, is ACTH22\u201339. Nature 301, 255\u2013258 (1983).","journal-title":"Nature"},{"key":"BFnrneph2011190_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02918598","volume":"3","author":"M Schoneshofer","year":"1984","unstructured":"Schoneshofer, M. & Goverde, H. J. Corticotropin in human plasma. General considerations. Surv. Immunol. Res. 3, 55\u201363 (1984).","journal-title":"Surv. Immunol. Res."},{"key":"BFnrneph2011190_CR21","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/jps.10442","volume":"92","author":"L Wan","year":"2003","unstructured":"Wan, L., Chen, Y. H. & Chang, T. W. Improving pharmacokinetic properties of adrenocorticotropin by site-specific lipid modification. J. Pharm. Sci. 92, 1882\u20131892 (2003).","journal-title":"J. Pharm. Sci."},{"key":"BFnrneph2011190_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00041552-199807000-00011","volume":"7","author":"Y Kohda","year":"1998","unstructured":"Kohda, Y., Chiao, H. & Star, R. A. alpha-Melanocyte-stimulating hormone and acute renal failure. Curr. Opin. Nephrol. Hypertens. 7, 413\u2013417 (1998).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph2011190_CR23","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1172\/JCI119272","volume":"99","author":"H Chiao","year":"1997","unstructured":"Chiao, H. et al. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99, 1165\u20131172 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011190_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jat.1191","volume":"27","author":"M Kolgazi","year":"2007","unstructured":"Kolgazi, M., Arbak, S. & Alican, I. The effect of alpha-melanocyte stimulating hormone on gentamicin-induced acute nephrotoxicity in rats. J. Appl. Toxicol. 27, 183\u2013188 (2007).","journal-title":"J. Appl. Toxicol."},{"key":"BFnrneph2011190_CR25","doi-asserted-by":"publisher","first-page":"F384","DOI":"10.1152\/ajprenal.00282.2004","volume":"290","author":"C Li","year":"2006","unstructured":"Li, C. et al. alpha-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction. Am. J. Physiol. Renal. Physiol. 290, F384\u2013F396 (2006).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"BFnrneph2011190_CR26","doi-asserted-by":"publisher","first-page":"510A","DOI":"10.1681\/ASN.2008020238","volume":"20","author":"R Gong","year":"2009","unstructured":"Gong, R., Ge, Y., Tolbert, E. M., Zhuang, S. & Dworkin, L. D. Renoprotection by adrenocorticotropin in experimental acute kidney injury. J. Am. Soc. Nephrol. 20, 510A (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011190_CR27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1172\/JCI113145","volume":"80","author":"DL Garcia","year":"1987","unstructured":"Garcia, D. L., Rennke, H. G., Brenner, B. M. & Anderson, S. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation. J. Clin. Invest. 80, 867\u2013874 (1987).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011190_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/ndt\/gfh110","volume":"19","author":"AL Berg","year":"2004","unstructured":"Berg, A. L. & Arnadottir, M. ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses. Nephrol. Dial. Transplant. 19, 1305\u20131307 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2011190_CR29","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1046\/j.1523-1755.1999.00675.x","volume":"56","author":"AL Berg","year":"1999","unstructured":"Berg, A. L., Nilsson-Ehle, P. & Arnadottir, M. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int. 56, 1534\u20131543 (1999).","journal-title":"Kidney Int."},{"key":"BFnrneph2011190_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.ajkd.2005.10.016","volume":"47","author":"C Ponticelli","year":"2006","unstructured":"Ponticelli, C. et al. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Am. J. Kidney Dis. 47, 233\u2013240 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2011190_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.5414\/CNP71637","volume":"71","author":"T Rauen","year":"2009","unstructured":"Rauen, T., Michaelis, A., Floege, J. & Mertens, P. R. Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1\u201324. Clin. Nephrol. 71, 637\u2013642 (2009).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2011190_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5414\/CNP62403","volume":"62","author":"L Picardi","year":"2004","unstructured":"Picardi, L. et al. ACTH therapy in nephrotic syndrome induced by idiopathic membranous nephropathy. Clin. Nephrol. 62, 403\u2013404 (2004).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2011190_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/DDDT.S17521","volume":"5","author":"AS Bomback","year":"2011","unstructured":"Bomback, A. S. et al. Treatment of resistant nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel. Drug Des. Develop. Ther. 5, 147\u2013153 (2011).","journal-title":"Drug Des. Develop. Ther."},{"key":"BFnrneph2011190_CR34","doi-asserted-by":"publisher","first-page":"306A","DOI":"10.1681\/ASN.2009020216","volume":"20","author":"LH Beck","year":"2009","unstructured":"Beck, L. H. et al. Treatment of idiopathic membranous nephropathy with ACTH is associated with a decline in anti-PLA2R antibody. J. Am. Soc. Nephrol. 20, 306A (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011190_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck, L. H. Jr et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361, 11\u201321 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011190_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0022-3476(64)80191-8","volume":"64","author":"AH Rosenblum","year":"1964","unstructured":"Rosenblum, A. H. & Rosenblum, P. Anaphylactic reactions to adrenocorticotropic hormone in children. J. Pediatr. 64, 387\u2013395 (1964).","journal-title":"J. Pediatr."},{"key":"BFnrneph2011190_CR37","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0272-6386(04)00868-6","volume":"44","author":"RJ Glassock","year":"2004","unstructured":"Glassock, R. J. The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum? Am. J. Kidney Dis. 44, 562\u2013566 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2011190_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1189\/jlb.0706426","volume":"81","author":"A Catania","year":"2007","unstructured":"Catania, A. The melanocortin system in leukocyte biology. J. Leukoc. Biol. 81, 383\u2013392 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2011190_CR39","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bmj.2.4790.897","volume":"2","author":"WS Symmers","year":"1952","unstructured":"Symmers, W. S. Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). Br. Med. J. 2, 897\u2013903 (1952).","journal-title":"Br. Med. J."},{"key":"BFnrneph2011190_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.56.1.1","volume":"56","author":"A Catania","year":"2004","unstructured":"Catania, A., Gatti, S., Colombo, G. & Lipton, J. M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56, 1\u201329 (2004).","journal-title":"Pharmacol. Rev."},{"key":"BFnrneph2011190_CR41","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","volume":"339","author":"G Remuzzi","year":"1998","unstructured":"Remuzzi, G. & Bertani, T. Pathophysiology of progressive nephropathies. N. Engl. J. Med. 339, 1448\u20131456 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011190_CR42","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0006-291X(88)81002-7","volume":"157","author":"EW Johnson","year":"1988","unstructured":"Johnson, E. W., Blalock, J. E. & Smith, E. M. ACTH receptor-mediated induction of leukocyte cyclic AMP. Biochem. Biophys. Res. Comm. 157, 1205\u20131211 (1988).","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"BFnrneph2011190_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1677\/jme.1.01485","volume":"33","author":"AP Lepique","year":"2004","unstructured":"Lepique, A. P. et al. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells. J. Mol. Endocrinol. 33, 623\u2013638 (2004).","journal-title":"J. Mol. Endocrinol."},{"key":"BFnrneph2011190_CR44","first-page":"825A","volume":"21","author":"H Wang","year":"2010","unstructured":"Wang, H., Jia, Z., Liu, G. & Yang, T. Adrenocorticotropic hormone attenuates diabetic nephropathy in Zucker diabetic fatty rats via inhibition of oxidative and inflammatory response. J. Am. Soc. Nephrol. 21, 825A (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011190_CR45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2460\/ajvr.1982.43.03.412","volume":"43","author":"JA Roth","year":"1982","unstructured":"Roth, J. A., Kaeberle, M. L. & Hsu, W. H. Effects of ACTH administration on bovine polymorphonuclear leukocyte function and lymphocyte blastogenesis. Am. J. Vet. Res. 43, 412\u2013416 (1982).","journal-title":"Am. J. Vet. Res."},{"key":"BFnrneph2011190_CR46","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1212\/WNL.26.10.915","volume":"26","author":"E Smith","year":"1976","unstructured":"Smith, E., Hammarstrom, L., Moller, E. & Matell, G. The effect of ACTH treatment on lymphocyte subpopulations in patients with myasthenia gravis. Neurology 26, 915\u2013918 (1976).","journal-title":"Neurology"},{"key":"BFnrneph2011190_CR47","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.4049\/jimmunol.175.7.4806","volume":"175","author":"A Cooper","year":"2005","unstructured":"Cooper, A. et al. Alpha-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J. Immunol. 175, 4806\u20134813 (2005).","journal-title":"J. Immunol."},{"key":"BFnrneph2011190_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-3083.2005.01565.x","volume":"61","author":"GN Andersen","year":"2005","unstructured":"Andersen, G. N. et al. Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes. Scand. J. Immunol. 61, 279\u2013284 (2005).","journal-title":"Scand. J. Immunol."},{"key":"BFnrneph2011190_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nri1984","volume":"7","author":"E Gonzalez-Rey","year":"2007","unstructured":"Gonzalez-Rey, E., Chorny, A. & Delgado, M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol. 7, 52\u201363 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph2011190_CR50","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ki.1991.232","volume":"40","author":"A Koyama","year":"1991","unstructured":"Koyama, A., Fujisaki, M., Kobayashi, M., Igarashi, M. & Narita, M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int. 40, 453\u2013460 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph2011190_CR51","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"KJ Tracey","year":"2002","unstructured":"Tracey, K. J. The inflammatory reflex. Nature 420, 853\u2013859 (2002).","journal-title":"Nature"},{"key":"BFnrneph2011190_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/ki.2008.94","volume":"74","author":"MM Yeboah","year":"2008","unstructured":"Yeboah, M. M. et al. Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int. 74, 62\u201369 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2011190_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cardiores.2004.03.029","volume":"63","author":"S Guarini","year":"2004","unstructured":"Guarini, S. et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc. Res. 63, 357\u2013365 (2004).","journal-title":"Cardiovasc. Res."},{"key":"BFnrneph2011190_CR54","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1111\/j.1523-1755.2005.09916.x","volume":"68","author":"A Cases","year":"2005","unstructured":"Cases, A. & Coll, E. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int. Suppl. 68, S87\u2013S93 (2005).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph2011190_CR55","first-page":"219","volume":"46","author":"BL Rayner","year":"1996","unstructured":"Rayner, B. L., Byrne, M. J. & van Zyl Smit, R. A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone. Clin. Nephrol. 46, 219\u2013224 (1996).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2011190_CR56","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/0140-6736(90)91118-T","volume":"335","author":"AJ Rabelink","year":"1990","unstructured":"Rabelink, A. J., Hene, R. J., Erkelens, D. W., Joles, J. A. & Koomans, H. A. Partial remission of nephrotic syndrome in patient on long-term simvastatin. Lancet 335, 1045\u20131046 (1990).","journal-title":"Lancet"},{"key":"BFnrneph2011190_CR57","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ki.1993.358","volume":"44","author":"ME Thomas","year":"1993","unstructured":"Thomas, M. E. et al. Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int. 44, 1124\u20131129 (1993).","journal-title":"Kidney Int."},{"key":"BFnrneph2011190_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/oxfordjournals.ndt.a092102","volume":"7","author":"PC Chan","year":"1992","unstructured":"Chan, P. C. et al. Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria. Nephrol. Dial. Transplant. 7, 93\u201399 (1992).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2011190_CR59","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1046\/j.1523-1755.2002.00664.x","volume":"62","author":"GM Ghiggeri","year":"2002","unstructured":"Ghiggeri, G. M. et al. Depletion of clusterin in renal diseases causing nephrotic syndrome. Kidney Int. 62, 2184\u20132194 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph2011190_CR60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1681\/ASN.V121143","volume":"12","author":"G Candiano","year":"2001","unstructured":"Candiano, G. et al. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 12, 143\u2013150 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011190_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0026-0495(94)90162-7","volume":"43","author":"AL Berg","year":"1994","unstructured":"Berg, A. L. & Nilsson-Ehle, P. Direct effects of corticotropin on plasma lipoprotein metabolism in man--studies in vivo and in vitro. Metabolism 43, 90\u201397 (1994).","journal-title":"Metabolism"},{"key":"BFnrneph2011190_CR62","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.ki.5001563","volume":"70","author":"MP Rastaldi","year":"2006","unstructured":"Rastaldi, M. P. et al. Glomerular clusterin is associated with PKC-alpha\/beta regulation and good outcome of membranous glomerulonephritis in humans. Kidney Int. 70, 477\u2013485 (2006).","journal-title":"Kidney Int."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.190","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:01:56Z","timestamp":1741996916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2011.190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,6]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["BFnrneph2011190"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2011.190","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,6]]}}}